Intuitive Surgical, Inc. $ISRG Stake Lowered by Argus Investors Counsel Inc.

Argus Investors Counsel Inc. decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.3% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 4,094 shares of the medical equipment provider’s stock after selling 53 shares during the quarter. Intuitive Surgical accounts for about 1.6% of Argus Investors Counsel Inc.’s investment portfolio, making the stock its 23rd biggest position. Argus Investors Counsel Inc.’s holdings in Intuitive Surgical were worth $2,225,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Chilton Capital Management LLC lifted its position in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares in the last quarter. Global Financial Private Client LLC grew its position in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 38 shares in the last quarter. Elite Financial Inc. acquired a new stake in Intuitive Surgical in the first quarter valued at $26,000. LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical in the first quarter valued at $30,000. Finally, TD Capital Management LLC lifted its stake in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.7%

Shares of NASDAQ:ISRG opened at $441.12 on Friday. The firm has a market cap of $158.13 billion, a PE ratio of 61.52, a PEG ratio of 4.62 and a beta of 1.61. The company’s 50 day moving average price is $469.43 and its two-hundred day moving average price is $501.49. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the company posted $1.78 earnings per share. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director owned 739 shares of the company’s stock, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on ISRG shares. Evercore ISI lifted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a report on Tuesday, July 8th. UBS Group raised their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a report on Wednesday, July 23rd. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Friday. Wells Fargo & Company raised their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Finally, Piper Sandler reissued an “overweight” rating and issued a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.